The independent source for health policy research, polling, and news.
KFF’s policy research provides facts and analysis on a wide range of policy issues and public programs.
KFF designs, conducts and analyzes original public opinion and survey research on Americans’ attitudes, knowledge, and experiences with the health care system to help amplify the public’s voice in major national debates.
KFF Health News is a national newsroom that produces in-depth journalism about health issues and is one of the organization’s core operating programs.
Secretary Kennedy's efforts to narrow the childhood vaccine schedule does not reflect the views of most parents, but KFF polling suggests it may have more appeal among President Trump's base.
This brief describes four key federal vaccine advisory committees and discusses policy issues and questions they currently face. The four committees are the Vaccines and Related Biological Products Advisory Committee (VRBPAC) at the Food and Drug Administration (FDA); the Advisory Committee on Immunization Practices (ACIP) at the Centers for Disease Control and Prevention (CDC); the National Vaccine Advisory Committee (NVAC) at the Department of Health and Human Services (HHS); and the Advisory Commission on Childhood…
This analysis assesses U.S. COVID-19 vaccine dose donations in order to gauge progress towards meeting stated global vaccination goals.
Fact sheet examining actions taken by the Trump administration and their impact on Gavi.
Fact sheet examining actions taken by the Trump administration and their impact on CEPI.
On August 5, 2026 the U.S. Food and Drug Administration approved the first-ever mRNA flu vaccine for adults 50 and older, following a trial of roughly 40,000 people. KFF polling in April 2025 found that most adults ages 50 and older were uncertain whether mRNA vaccines are safe.
Examines the White House’s latest Executive Order seeking to reshape U.S. childhood vaccine recommendations, including a directive to separate MMR vaccines and use a new HHS task force for federal recommendations. It finds that the order is unlikely to have an immediate or sweeping effect on U.S. vaccine policy given courts blocked earlier, similar administration actions, and states are increasingly decoupling their policies from federal recommendations.
KFF is collecting and analyzing data on COVID-19 vaccinations by race/ethnicity to gain increased insight who is receiving the vaccine and whether some groups are facing disparities in vaccination.
This analysis updates the approaches states are taking to manage the limited initial supply of COVID-19 vaccines based on revised federal guidance and balance the desire to vaccinate those at greatest risk first with the need to ensure a fast and effective statewide vaccination effort. It includes a state data table.
When a COVID-19 vaccine becomes available, all or most people living in the country will need to get vaccinated in order to maximize its benefits and provide adequate immunity nationwide. That could present a daunting challenge for state and local health officials, as a new KFF analysis shows vaccination rates for the annual flu vaccine vary widely across states as well as by race and ethnicity, age, and other demographic characteristics. The flu vaccine provides…
© 2026 KFF
